Updated 02:01 GMT, 17 Nov 2026 SPX 7,416.59 -1.92% NDX 27,197.15 -2.67% VIX 22.91 +18.70% GOLD 3,868.50 -0.46% CL 85.14 -3.86% BTC 65,305.22 0.00%
NAS100 27,197 −2.67% S&P 7,417 −1.92% GOLD $3,869 −0.46% BTC $65,305 VIX 22.91 +18.70% latest tape · as of 02:01 UTC
The Screen · Industrials · Building Products & Equipment

Griffon Corporation logoGriffon Corporation

GFF · the NYSE · USD · Market cap $4.9B · 5,100 employees

Griffon Corporation, through its subsidiaries, provides home and building, and consumer and professional products in the United States, Europe, Canada, Australia, and internationally.

FAIL · Does not pass the screen
105.16 USD

Price as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago

Screened 2026-11-13 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price105.16 USD at the 13 Nov 2026 close
  • Our value readOvervalued vs our fair value, as of 13 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans to puts (put/call 16.64)
  • Last reviewed13 Nov 2026 (4 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $88.26 to $101.50, base estimate $88.26 (screen dated 2026-11-13).

Current read
Markup ?
Overvalued · screened 2026-11-13
  • Trend Markup
  • Insiders insiders sold, $833,307, latest filing 2026-11-05
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 16.64, read 2026-11-15
  • Ethical does not pass the values gate
Price105.16 USD
Fair value88.26
Ethical score70.0/100
Value readOvervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-11-11Read Markup104.38+0.7% to today ✓Accumulation gives way to Markup after an 8% rise in 11 days
2026-10-31Read Accumulation97.04+8.4% to today ✓Markdown gives way to Accumulation
2026-10-24Read Markdown94.99+10.7% to today Accumulation gives way to Markdown first Markdown read since October
2026-10-17Read Accumulation92.23+14.0% to today ✓Markdown gives way to Accumulation

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Griffon Corporation holds its Markup at $105.16. The statistical read favours the sellers, held for 52 days.

As held on the ledger · 2026-11-13
PhaseMarkup
Quantitative stateThe statistical read favours the sellers, held for 52 days
Price at the screen$105.16
Valuation23.17 trailing · 17.64 forward price to earnings
Values screenFAIL · score 70.0
Beta1.44
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 77.15% Below 33% Interest-bearing debt is 77.1% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 18.89% Below 49% Money owed to the company is 18.9% of assets, under the 49% limit. Pass
Revenue purity 0.09% Below 5% Only 0.1% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Griffon's business is in a permissible area, but its interest-bearing debt is about 77% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when GFF's ethical verdict changes

Today GFF does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our $88.26 fair value estimate, 7.00% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

88.26Conservative88.26Base case101.50Growth case 105.16Price

Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 19.1% above the base estimate.

The Street's Range
120.00Street low 125.00Street average 135.00Street high 105.16Price

Third-party analyst targets: 7 covering, consensus Strong Buy. The average target sits +19% from the screen price.

Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.

Price History & Projections

Where our models see it going: fair-value estimate $88.26, with a range of $88.26 to $101.50, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Cyclical Builder Faces No Margin of Safety

Walk into any hardware aisle and you see the same pattern. Demand for doors, windows and tools rises and falls with housing cycles that no one controls. Griffon sits right in that swing, yet the shares trade eleven percent above our fair value with revenue already slipping one percent and margins at zero. The high return on equity looks impressive until you remember it can vanish the moment volumes turn.

Forward earnings sit at fifteen point nine times, a multiple that flatters only while the cycle peaks. Analysts still push a strong buy and a much higher target, but the numbers show no growth runway and an unknown moat. The ethical screen clears, yet that alone does not turn a cyclical business into a sound holding when price already embeds optimism.

The real danger is the classic trap. Low growth plus a mid-teens multiple often signals peak earnings rather than a bargain. Investors chasing the analyst chorus could watch both earnings and the rating compress together once housing slows. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E17.6xexpensive even after accounting for its growth
Trailing P/E23.2xa premium valuation
EPS, trailing4.64
EPS, forward6.10
Revenue growth+7.0%slow but positive growth
Profit margin7.0%thin but positive margins
Return on equity227.5%an exceptional return on shareholder capital
FCF yield9.14%
Dividend yield1.00%
Debt to equity10.35heavy leverage: higher risk if revenue softens
Current ratio2.41comfortably covers its short-term bills
Beta1.44moves a little more than the market
Short interest, float0.05%
52-week range65.01 - 108.57
Market cap$4.9B
Employees5,100

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

GFF trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-16 Markup $105.16 +0.0% Entry 16

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (7 analysts) rates it none, with a mean price target of $118. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-15 Markup $105.16 +0.0% Entry 15

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (7 analysts) rates it none, with a mean price target of $118. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-14 Markup $105.16 +0.3% Entry 14

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (7 analysts) rates it none, with a mean price target of $118. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-13 Markup $104.84 -1.2% Entry 13

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (7 analysts) rates it none, with a mean price target of $118. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-12 Markup $106.16 +1.7% Entry 12

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (7 analysts) rates it none, with a mean price target of $118. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-11 Markup · changed $104.38 +3.3% Entry 11

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 15% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (7 analysts) rates it none, with a mean price target of $118. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-07 Accumulation $101.03 +4.1% Entry 10

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (7 analysts) rates it none, with a mean price target of $118. Insiders have been net sellers over the past quarter.

2026-10-31 Accumulation · changed $97.04 +2.2% Entry 9

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (7 analysts) rates it none, with a mean price target of $118. Insiders have been net sellers over the past quarter.

2026-10-24 Markdown · changed $94.99 +3.0% Entry 8

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 3.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (7 analysts) rates it none, with a mean price target of $118. Insiders have been net sellers over the past quarter.

2026-10-17 Accumulation · changed $92.23 -1.1% Entry 7

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (7 analysts) rates it none, with a mean price target of $118. Insiders have been net sellers over the past quarter.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on GFF

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in GFF's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · GFF
DateInsiderTitleTypeSharesValue
2026-11-05 Mehmel Robert F Pres, COO S - Sale 7,743 $833,307
2026-08-05 Harris Brian G EVP, CFO S - Sale 11,050 $1,141,111
2026-08-05 Kramer Ronald J COB, CEO S - Sale 100,000 $10,241,980
2026-08-05 Mehmel Robert F Pres, COO S - Sale 37,061 $3,829,214

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $85.97 +5.0% $0.22 $1,052 +5.2%
2 months $77.99 +15.7% $0.22 $1,160 +16.0%
3 months $69.88 +29.2% $0.22 $1,295 +29.5%
6 months $76.84 +17.5% $0.44 $1,180 +18.0%
1 year $71.21 +26.8% $0.84 $1,279 +27.9%
2 years $63.78 +41.5% $1.53 $1,439 +43.9%
3 years $35.47 +154.5% $2.11 $2,604 +160.4%
5 years $20.90 +331.9% $6.87 $4,648 +364.8%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever GFF does next, these words stay.

Griffon Corporation · GFF · Markup · $105.16
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.